Limoneira (NASDAQ:LMNR – Get Free Report) will likely be releasing its earnings data after the market closes on Wednesday, March 12th. Analysts expect Limoneira to post earnings of ($0.17) per share and revenue of $40.70 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.
Limoneira Stock Down 2.6 %
Shares of LMNR opened at $21.32 on Tuesday. The stock has a market cap of $384.72 million, a price-to-earnings ratio of 56.11 and a beta of 0.46. The company has a 50-day moving average price of $23.03 and a two-hundred day moving average price of $25.20. The company has a quick ratio of 0.69, a current ratio of 0.74 and a debt-to-equity ratio of 0.21. Limoneira has a 12 month low of $18.30 and a 12 month high of $29.22.
Limoneira Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Monday, December 30th were issued a dividend of $0.075 per share. This represents a $0.30 annualized dividend and a dividend yield of 1.41%. The ex-dividend date was Monday, December 30th. Limoneira’s payout ratio is 78.95%.
Analyst Ratings Changes
Read Our Latest Stock Analysis on LMNR
About Limoneira
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons. The company also grows avocado, oranges, and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Valencia oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, and wine grapes.
See Also
- Five stocks we like better than Limoneira
- Insider Trades May Not Tell You What You Think
- How to Protect Your Portfolio When Inflation Is Rising
- What Are Treasury Bonds?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What is a Death Cross in Stocks?
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.